Table 3.
Clinically significant outcomes | β | 95% CI | pa |
---|---|---|---|
Fitness (>50 meter increase on the 6-MWT)b | −4.39 | −8.35 to −0.44 | 0.030 |
Weight loss (≥5%) | −2.58 | −5.72 to 0.55 | 0.106 |
Weight loss (≥10%) | −4.38 | −8.65 to −0.12 | 0.044 |
Cardiovascular risk reduction (≥5% or >50 meter increase on the 6-MWT) |
−3.41 | −6.45 to −0.37 | 0.028 |
P-values from linear regression models controlling for treatment group, study (RCT 1 or RCT 2), age, gender, mental health diagnosis, race, and use of antidepressant.
Fitness was measured using the 6-Minute Walk Test (6-MWT), which measures the number of meters that an individual can walk in 6 minutes. Higher values indicate better fitness.